147
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells

, , , , , & show all
Pages 293-314 | Published online: 24 Feb 2014

References

  • Ahn JS Moon SH Kim J Chung HM Kim JK Identification of differentially expressed genes in human embryonic stem cell-derived endothelial cells using suppression subtractive hybridization Stem Cells Dev 2010 19 8 1249 1256 19817571
  • Meyn RE Stephens LC Hunter NR Milas L Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas Int J Cancer 1995 60 5 725 729 7860148
  • Miles GD Seiler M Rodriguez L Rajagopal G Bhanot G Identifying microRNA/mRNA dysregulations in ovarian cancer BMC Res Notes 2012 5 164 22452920
  • Schultz NA Werner J Willenbrock H MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma Mod Path 2012 25 12 1609 1622 22878649
  • Chao A Lin CY Lee YS Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2 Oncogene 2012 31 6 764 775 21725366
  • Bloomston M Frankel WL Petrocca F MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis JAMA 2007 297 17 1901 1908 17473300
  • Lee KH Chen YL Yeh SD MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation Oncogene 2009 28 38 3360 3370 19597470
  • Uhlmann S Mannsperger H Zhang JD Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer Mol Syst Biol 2012 8 570 22333974
  • Krichevsky AM Gabriely G miR-21: a small multi-faceted RNA J Cell Mol Med 2009 13 1 39 53 19175699
  • Singh A Settleman J EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer Oncogene 2010 29 34 4741 4751 20531305
  • Blower PE Chung JH Verducci JS MicroRNAs modulate the chemosensitivity of tumor cells Mol Cancer Ther 2008 7 1 1 9 18187804
  • Bian HB Pan X Yang JS Wang ZX De W Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549) J Exp Clin Cancer Res 2011 30 20 21329503
  • Hamano R Miyata H Yamasaki M Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway Clin Cancer Res 2011 17 9 3029 3038 21248297
  • Zhou M Liu Z Zhao Y MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression J Biol Chem 2010 285 28 21496 21507 20460378
  • Nam EJ Yoon H Kim SW MicroRNA expression profiles in serous ovarian carcinoma Clin Cancer Res 2008 14 9 2690 2695 18451233
  • Hu X Macdonald DM Huettner PC A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer Gynecol Oncol 2009 114 3 457 464 19501389
  • Phillips HS Kharbanda S Chen R Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis Cancer Cell 2006 9 3 157 173 16530701
  • Kim YW Kwon C Liu JL Kim SH Kim S Cancer association study of aminoacyl-tRNA synthetase signaling network in glioblastoma PloS one 2012 7 8 e40960 22952576
  • Itamochi H Oishi T Shimada M Inhibiting the mTOR pathway synergistically enhances cytotoxicity in ovarian cancer cells induced by etoposide through upregulation of c-Jun Clin Cancer Res 2011 17 14 4742 4750 21610153
  • Bazzaro M Santillan A Lin Z Myosin II co-chaperone general cell UNC-45 overexpression is associated with ovarian cancer, rapid proliferation, and motility Am J Pathol 2007 171 5 1640 1649 17872978
  • Singer G Oldt R3rd Cohen Y Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma J Natl Cancer Inst 2003 95 6 484 486 12644542
  • Kim YW Bae SM Battogtokh G Bang HJ Ahn WS Synergistic anti-tumor effects of combination of photodynamic therapy and arsenic compound in cervical cancer cells: in vivo and in vitro studies PloS one 2012 7 6 e38583 22715393
  • Yan M Xu H Waddell N Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers Breast Cancer Res 2012 14 2 R69 22537934
  • Pradervand S Weber J Thomas J Impact of normalization on miRNA microarray expression profiling RNA 2009 15 3 493 501 19176604
  • Griffiths-Jones S Saini HK van Dongen S Enright AJ miRBase: tools for microRNA genomics Nucleic Acids Res 2008 36 Database issue D154 D158 17991681
  • Creighton CJ Hernandez-Herrera A Jacobsen A Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma PloS one 2012 7 3 e34546 22479643
  • Ahmet I Spangler E Shukitt-Hale B Joseph JA Ingram DK Talan M Survival and cardioprotective benefits of long-term blueberry enriched diet in dilated cardiomyopathy following myocardial infarction in rats PloS One 2009 4 11 e7975 19936253
  • Kim YW Liu TJ Koul D Identification of novel synergistic targets for rational drug combinations with PI3 kinase inhibitors using siRNA synthetic lethality screening against GBM Neuro Oncol 2011 13 4 367 375 21430111
  • Yi C Wang Q Wang L MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma Oncogene 2012 31 41 4421 4433 22249270
  • Lu Y Govindan R Wang L MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer Carcinogenesis 2012 33 5 1046 1054 22331473
  • Li D Zhao Y Liu C Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer Clin Cancer Res 2011 17 7 1722 1730 21350001
  • Xu T Zhu Y Xiong Y Ge YY Yun JP Zhuang SM MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells Hepatology 2009 50 1 113 121 19441017
  • Liu L Chen L Xu Y Li R Du X microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells Biochem Biophys Res Commun 2010 400 2 236 240 20727858
  • Yamakuchi M Lotterman CD Bao C P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis Proc Natl Acad Sci U S A 2010 107 14 6334 6339 20308559
  • Network TCGAR Integrated genomic analyses of ovarian carcinoma Nature 2011 474 7353 609 615 21720365
  • Yang D Sun Y Hu L Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer Cancer Cell 2013 23 2 186 199 23410973
  • Kim YW Bae SM Lim H Kim YJ Ahn WS Development of multiplexed bead-based immunoassays for the detection of early stage ovarian cancer using a combination of serum biomarkers PloS one 2012 7 9 e44960 22970327
  • Calin GA Croce CM MicroRNA signatures in human cancers Nature Rev Cancer 2006 6 11 857 866 17060945
  • Wyman SK Parkin RK Mitchell PS Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries PloS One 2009 4 4 e5311 19390579
  • Bearfoot JL Choong DY Gorringe KL Campbell IG Genetic analysis of cancer-implicated MicroRNA in ovarian cancer Clin Cancer Res 2008 14 22 7246 7250 19010840
  • Yu SL Chen HY Chang GC MicroRNA signature predicts survival and relapse in lung cancer Cancer Cell 2008 13 1 48 57 18167339
  • Eitan R Kushnir M Lithwick-Yanai G Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients Gynecol Oncol 2009 114 2 253 259 19446316
  • Zhao X Yang L Hu J Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells J Exp Clin Cancer Res 2011 30 55 21569481
  • Zhu H Wu H Liu X Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells Biochem Pharmacol 2008 76 5 582 588 18619946
  • Creighton CJ Fountain MD Yu Z Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers Cancer Res 2010 70 5 1906 1915 20179198
  • Fu X Tian J Zhang L Chen Y Hao Q Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells FEBS Letters 2012 586 9 1279 1286 22465665
  • Sorrentino A Liu CG Addario A Peschle C Scambia G Ferlini C Role of microRNAs in drug-resistant ovarian cancer cells Gynecol Oncol 2008 111 3 478 486 18823650
  • Pan J Hu H Zhou Z Tumor-suppressive miR-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells Oncol Rep 2010 24 1 105 112 20514450
  • Su H Yang JR Xu T MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity Cancer Res 2009 69 3 1135 1142 19155302
  • Zhou X Zhao F Wang ZN Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation Oncol Rep 2012 27 2 447 454 21971665
  • Holleman A Chung I Olsen RR miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo Oncogene 2011 30 43 4386 4398 21552288
  • Sakamoto M Kondo A Kawasaki K Analysis of gene expression profiles associated with cisplatin resistance in human ovarian cancer cell lines and tissues using cDNA microarray Human Cell 2001 14 4 305 315 11925933
  • Dimanche-Boitrel MT Micheau O Hammann A Contribution of the cyclin-dependent kinase inhibitor p27KIP1 to the confluence-dependent resistance of HT29 human colon carcinoma cells Int J Cancer 1998 77 5 796 802 9688315
  • Eymin B Haugg M Droin N Sordet O Dimanche-Boitrel MT Solary E p27Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells Oncogene 1999 18 7 1411 1418 10050878
  • Liu ZY Zhang GL Wang MM Xiong YN Cui HQ MicroRNA-663 targets TGFB1 and regulates lung cancer proliferation Asian Pac J Cancer Prev 2011 12 11 2819 2823 22393947
  • Hu H Li S Cui X The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2) J Biol Chem 2013 288 16 10973 10985 23436656
  • Guo XB Jing CQ Li LP Down-regulation of miR-622 in gastric cancer promotes cellular invasion and tumor metastasis by targeting ING1 gene World J Gastroenterol 2011 17 14 1895 1902 21528065
  • Gunduz M Demircan K Gunduz E Katase N Tamamura R Nagatsuka H Potential usage of ING family members in cancer diagnostics and molecular therapy Curr Drug Targets 2009 10 5 465 476 19442118
  • Riaz M van Jaarsveld MT Hollestelle A miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs Breast Cancer Res 2013 15 2 R33 23601657
  • Long Q Johnson BA Osunkoya AO Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy Am J Pathol 2011 179 1 46 54 21703393